Neural regulation of tumor progression: implications for hepatocellular carcinoma - Report - MDSpire

Neural regulation of tumor progression: implications for hepatocellular carcinoma

  • By

  • Yalin Chen

  • Zhanghui Long

  • Yuan-Sheng Zang

  • Dong Wu

  • June 19, 2026

  • 0 min

Share

Clinical Report: Neural Influence on Tumor Development in HCC

Overview

The nervous system plays an active role in the regulation of tumor dynamics in hepatocellular carcinoma (HCC), influencing processes such as tumor proliferation and immune evasion. This review highlights the complex interactions between neural signals and tumor biology.

Background

Understanding the role of the nervous system in cancer progression is crucial, as it challenges the traditional view of nerves as passive structures. In HCC, neural activity can modulate inflammation and metabolism, potentially contributing to the transition from chronic liver disease to malignancy.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • The nervous system actively regulates oncogenesis through complex interactions with tumor cells.
  • Neural signals promote tumor proliferation, invasion, and immune evasion in HCC.
  • Malignant cells can induce neural remodeling, enhancing neuronal excitability.
  • Neuro-immune crosstalk plays a role in shaping the tumor microenvironment.
  • Understanding the neural circuits involved in HCC progression is essential.

Clinical Implications

Clinicians should consider the implications of neuro-tumor interactions in HCC.

Conclusion

The interplay between the nervous system and tumor biology in HCC requires further exploration.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic
  2. The ASCO Post, December 2024 -- Improving Hepatocellular Carcinoma Outcomes Through Enhanced Immunotherapy
  3. Journal of Gastroenterology, 2013 -- Hepatocellular Carcinoma Among Individuals with Chronic Hepatitis C Virus Infection in the Asia-Pacific Area
  4. ESMO Diagnosis, Treatment and Follow-up of Hepatocellular Carcinoma Guideline Summary - Guideline Central, 2025
  5. FDA, 2025 -- FDA approves nivolumab with ipilimumab for unresectable or metastatic hepatocellular carcinoma
  6. Journal of Neuro-Oncology — Regulatory Mechanisms of Diffuse Glioma Growth and Invasion in the Central Nervous System: Insights from Single-Unit Physiology to Circuit Alterations
  7. ESMO Diagnosis, Treatment and Follow-up of Hepatocellular Carcinoma Guideline Summary - Guideline Central
  8. FDA approves nivolumab with ipilimumab for unresectable or metastatic hepatocellular carcinoma | FDA
  9. Nervous system in hepatocellular carcinoma: Correlation, mechanisms, therapeutic implications, and future perspectives - ScienceDirect

Original Source(s)

Related Content